Suppr超能文献

SUP-ICU试验中肠内营养与结局的关联:探索性事后分析结果

Associations between enteral nutrition and outcomes in the SUP-ICU trial: Results of exploratory post hoc analyses.

作者信息

Borthwick Mark, Granholm Anders, Marker Søren, Krag Mette, Lange Theis, Wise Matt P, Bendel Stepani, Keus Frederik, Guttormsen Anne Berit, Schefold Joerg C, Wetterslev Jørn, Perner Anders, Møller Morten Hylander

机构信息

Departments of Pharmacy and Critical Care, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.

出版信息

Acta Anaesthesiol Scand. 2024 Oct;68(9):1244-1253. doi: 10.1111/aas.14471. Epub 2024 Jun 12.

Abstract

BACKGROUND

Enteral nutrition may affect risks of gastrointestinal bleeding, pneumonia and mortality in critically ill patients and may also modify the effects of pharmacological stress ulcer prophylaxis. We undertook post hoc analyses of the stress ulcer prophylaxis in the intensive care unit trial to assess for any associations and interactions between enteral nutrition and pantoprazole.

METHODS

Extended Cox models with time-varying co-variates and competing events were used to assess potential associations, adjusted for baseline severity of illness. Potential interactions between daily enteral nutrition and allocation to pantoprazole on outcomes were similarly assessed.

RESULTS

Enteral nutrition was associated with lower risk of clinically important gastrointestinal bleeding (cause-specific hazard ratio [HR]: 0.29, 95% confidence interval: [CI] 0.19-0.44, p < .001), higher risk of pneumonia (HR: 1.44, 95% CI: 1.14-1.82, p = .003), and lower risk of all-cause mortality (HR: 0.22, 95% CI: 0.18-0.27, p < .001). Enteral nutrition with allocation to pantoprazole was associated with a lower risk of mortality (HR: 0.27, 95% CI: 0.21-0.35, p < .001), similar to enteral nutrition with allocation to placebo (HR: 0.17, 95% CI: 0.13-0.23, p < .001). Allocation to pantoprazole with no enteral nutrition had little effect on mortality (HR: 0.83, 95% CI: 0.63-1.09, p = .179), whilst allocation to pantoprazole and receipt of enteral nutrition was mostly compatible with increased all-cause mortality (HR: 1.27, 95% CI: 0.99-1.64, p = .061). The test of interaction between enteral nutrition and pantoprazole treatment allocation for all-cause mortality was statistically significant (p = .024).

CONCLUSIONS

Enteral nutrition was associated with an increased risk of pneumonia and a reduced risk of gastrointestinal bleeding. The interaction between pantoprazole and enteral nutrition suggesting an increased risk of mortality requires further study.

摘要

背景

肠内营养可能影响重症患者胃肠道出血、肺炎风险及死亡率,还可能改变药物性应激性溃疡预防措施的效果。我们对重症监护病房试验中的应激性溃疡预防措施进行事后分析,以评估肠内营养与泮托拉唑之间的任何关联和相互作用。

方法

使用带有时间变化协变量和竞争事件的扩展Cox模型评估潜在关联,并根据疾病基线严重程度进行调整。同样评估每日肠内营养与泮托拉唑分配对结局的潜在相互作用。

结果

肠内营养与具有临床意义的胃肠道出血风险较低相关(病因特异性风险比[HR]:0.29,95%置信区间:[CI]0.19 - 0.44,p <.001),肺炎风险较高(HR:1.44,95%CI:1.14 - 1.82,p =.003),全因死亡率风险较低(HR:0.22,95%CI:0.18 - 0.27,p <.001)。分配到泮托拉唑的肠内营养与较低的死亡率风险相关(HR:0.27,95%CI:0.21 - 0.35,p <.001),类似于分配到安慰剂的肠内营养(HR:0.17,95%CI:0.13 - 0.23,p <.001)。未接受肠内营养而分配到泮托拉唑对死亡率影响不大(HR:0.83,95%CI:0.63 - 1.09,p =.179),而分配到泮托拉唑并接受肠内营养大多与全因死亡率增加相符(HR:1.27,95%CI:0.99 - 1.64,p =.061)。肠内营养与泮托拉唑治疗分配对全因死亡率的相互作用检验具有统计学意义(p =.024)。

结论

肠内营养与肺炎风险增加和胃肠道出血风险降低相关。泮托拉唑与肠内营养之间的相互作用提示死亡率风险增加,这需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验